التفاصيل البيبلوغرافية
| العنوان: |
Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum. |
| المؤلفون: |
Cefalu, William T., Bray, George A., Home, Philip D., Garvey, W. Timothy, Klein, Samuel, Pi-Sunyer, F. Xavier, Hu, Frank B., Raz, Itamar, Van Gaal, Luc, Wolfe, Bruce M., Ryan, Donna H. |
| المصدر: |
Diabetes Care; Aug2015, Vol. 38 Issue 8, p1567-1582, 16p, 3 Diagrams, 3 Charts, 3 Graphs |
| مصطلحات موضوعية: |
DISEASE prevalence, OBESITY, TYPE 2 diabetes risk factors, CARDIOVASCULAR diseases risk factors, DIABETES prevention, TYPE 2 diabetes prevention, PREVENTION of obesity, HYPOGLYCEMIC agents, ANTIOBESITY agents, BEHAVIOR, BEHAVIOR therapy, BODY weight, DIABETIC angiopathies, FORECASTING, MEDICAL protocols, METABOLIC disorders, TYPE 2 diabetes, BARIATRIC surgery, PATIENT safety, WEIGHT loss, TREATMENT effectiveness, PREVENTION, THERAPEUTICS |
| مصطلحات جغرافية: |
UNITED States |
| مستخلص: |
As obesity rates increase, so too do the risks of type 2 diabetes, cardiovascular disease, and numerous other detrimental conditions. The prevalence of obesity in U.S. adults more than doubled between 1980 and 2010, from 15.0 to 36.1%. Although this trend may be leveling off, obesity and its individual, societal, and economic costs remain of grave concern. In June 2014, a Diabetes Care Editors' Expert Forum convened to review the state of obesity research and discuss the latest prevention initiatives and behavioral, medical, and surgical therapies. This article, an outgrowth of the forum, offers an expansive view of the obesity epidemic, beginning with a discussion of its root causes. Recent insights into the genetic and physiological factors that influence body weight are reviewed, as are the pathophysiology of obesity-related metabolic dysfunction and the concept of metabolically healthy obesity. The authors address the crucial question of how much weight loss is necessary to yield meaningful benefits. They describe the challenges of behavioral modification and predictors of its success. The effects of diabetes pharmacotherapies on body weight are reviewed, including potential weight-neutral combination therapies. The authors also summarize the evidence for safety and efficacy of pharmacotherapeutic and surgical obesity treatments. The article concludes with an impassioned call for researchers, clinicians, governmental agencies, health policymakers, and health-related industries to collectively embrace the urgent mandate to improve prevention and treatment and for society at large to acknowledge and manage obesity as a serious disease. [ABSTRACT FROM AUTHOR] |
|
Copyright of Diabetes Care is the property of American Diabetes Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder